Sulfatrim
NDC Package 17856-0007-2
Package Information
Sulfatrim is a medication a combination of two antibiotics: sulfamethoxazole and trimethoprim. Marketed by Atlantic Biologicals Corps, this product is identified by NDC 17856-0007 and is authorized under FDA application NDA018615.
Identification & Billing
- RxCUI: 208406 - SULFATRIM 200 MG / 40 MG in 5 mL Oral Suspension
- RxCUI: 208406 - sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension [Sulfatrim]
- RxCUI: 208406 - SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension [Sulfatrim]
- RxCUI: 208406 - Sulfatrim (sulfamethoxazole 200 MG / trimethoprim 40 MG) per 5 ML Oral Suspension
- RxCUI: 313134 - sulfamethoxazole 200 MG / trimethoprim 40 MG in 5 mL Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corps
- 17856-0007 - Sulfatrim
- 17856-0007-2 - 20 mL in 1 CUP
- 17856-0007 - Sulfatrim
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-0007). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-0007-2 identifies a specific commercial package of 20 ml in 1 cup of Sulfatrim, labeled by Atlantic Biologicals Corps. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corps on July 01, 1983. The current certification is valid through December 31, 2018.
What are the primary indications for this medication?
This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used in children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Atlantic Biologicals Corps product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856000702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
